TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
3/14/24 20:54 | 3/13/24 | APRE | Aprea Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Hamill John P. | PA | O | SrVP,CFO | P.d | 7 | 7.29 | 0 | 1 | 7 | 16 | D | ||||||||||||||
7/26/22 16:38 | 7/26/22 | WINT | Windtree Therapeutics Inc /de/ | DE | Health | BioPrd | Biological Products, (No Diag | Hamill John P. | PA | O | SVP,CFO | P | 1 | 0.3666 | 0 | 3 | 4 | 73 | D | ||||||||||||||
4/19/21 07:49 | 4/16/21 | WINT | Windtree Therapeutics Inc /de/ | DE | Health | BioPrd | Biological Products, (No Diag | Hamill John P. | PA | O | SVP,CFO | P | 2 | 2.07 | 0 | 1 | 40 | 4 | D | ||||||||||||||
3/25/21 16:44 | 3/25/21 | WINT | Windtree Therapeutics Inc /de/ | DE | Health | BioPrd | Biological Products, (No Diag | Hamill John P. | PA | O | SVP,CFO | P.d | 5 | 3.25 | 0 | 2 | 150 | 3 | D | ||||||||||||||
10/9/20 08:06 | 10/7/20 | WINT | Windtree Therapeutics Inc /de/ | DE | Health | BioPrd | Biological Products, (No Diag | Hamill John P. | PA | O | SVP,CFO | P | 5 | 5.27 | 0 | 1 | New | 1 | D | ||||||||||||||
6/4/19 16:52 | 5/31/19 | TRVN | Trevena Inc | DE | Health | Drug | Pharmaceutical Preparations | Hamill John P. | PA | O | VP Fin,P | P | 9 | 1.16 | 0 | 8 | 10 | 82 | D |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |